Counting Processes and Survival Analysis

Fleming, Thomas R.; Harrington, David P.

doi:10.1002/9781118150672

Cited by 719 publications

(1,073 citation statements)

References 0 publications

Supporting

Mentioning

1,028

Contrasting

Unclassified

Order By: Relevance

“…Therefore, discontinuous time intervals were considered. Discontinuous time intervals remove the patients from the risk sets for some time intervals but not from the study (18,19).…”

Section: Statistical Analysesmentioning

confidence: 99%

Do proton‐pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?

Rahme¹,

Barkun²,

Toubouti³

et al. 2007

Arthritis & Rheumatism

View full text Add to dashboard Cite

Objective. Celecoxib has a superior upper-gastrointestinal (GI) safety profile compared with nonselective nonsteroidal antiinflammatory drugs (NS-NSAIDs). It is unclear whether the utilization of a proton-pump inhibitor (PPI) with celecoxib confers additional protection in elderly patients. We assessed the association between GI hospitalizations and use of celecoxib with a PPI versus celecoxib alone, and NS-NSAIDs with a PPI or NS-NSAIDs alone in elderly patients.

show abstract

“…Therefore, discontinuous time intervals were considered. Discontinuous time intervals remove the patients from the risk sets for some time intervals but not from the study (18,19).…”

Section: Statistical Analysesmentioning

confidence: 99%

Do proton‐pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?

Rahme¹,

Barkun²,

Toubouti³

et al. 2007

Arthritis & Rheumatism

View full text Add to dashboard Cite

show abstract

“…Furthermore, the shared frailty model (2.1) can be easily extended to a multilevel structure in which patients, nested within hospitals, have recurrent event times as in the CGD data (Fleming and Harrington, 1991). Let T ijk be the kth recurrent event time of the jth patient in the i the cluster (center).…”

Section: A Formulation Of Frailty Modelsmentioning

confidence: 99%

“…For the illustration we re-analyze two practical examples (e.g., Ha et al, 2012b) using two well-know real data sets; one is kidney infection data (McGilchrist and Aisbett, 1991) and the other is the chronic granulomatous disease (CGD) recurrent data (Fleming and Harrington, 1991).…”

Section: Practical Examplesmentioning

confidence: 99%

A visualizing method for investigating individual frailties using frailtyHL R-package

Ha¹,

Noh²

2013

Journal of the Korean Data and Information Science Society

View full text Add to dashboard Cite

For analysis of clustered survival data, the inferences of parameters in semi-parametric frailty models have been widely studied. It is also important to investigate the potential heterogeneity in event times among clusters (e.g. centers, patients). For purpose of this analysis, the interval estimation of frailty is useful. In this paper we propose a visualizing method to present confidence intervals of individual frailties across clusters using the frailtyHL R-package, which is implemented from h-likelihood methods for frailty models. The proposed method is demonstrated using two practical examples.

show abstract

“…We used a Mayo Clinic data set [27], which contains the medical records of 314 primary biliary cirrhosis patients with the following recorded features:…”

Section: Reclassification With An Oracle Vs Reclassification With Comentioning

confidence: 99%

Classification integration and reclassification using constraint databases

Révész¹,

Triplet²

2010

Artificial Intelligence in Medicine

View full text Add to dashboard Cite

Counting Processes and Survival Analysis

Cited by 719 publications

References 0 publications

Do proton‐pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?

Do proton‐pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?

A visualizing method for investigating individual frailties using frailtyHL R-package

Classification integration and reclassification using constraint databases

Contact Info

Product

Resources

About